REPETTO, MATTEO
REPETTO, MATTEO
Universita' degli Studi di MILANO
A robust goal programming model for transfer pricing risk hedging: Preliminary results
2019 M. Repetto, D. La Torre, D. Liuzzi
ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research
2021 C. Belli, F. Penault-Llorca, M. Ladanyi, N. Normanno, J.-. Scoazec, L. Lacroix, J.S. Reis-Filho, V. Subbiah, J.F. Gainor, V. Endris, M. Repetto, A. Drilon, A. Scarpa, F. Andre, J.-. Douillard, G. Curigliano
High-performance prediction models for prostate cancer radiomics
2023 L.J. Isaksson, M. Repetto, P.E. Summers, M. Pepa, M. Zaffaroni, M.G. Vincini, G. Corrao, G.C. Mazzola, M. Rotondi, F. Bellerba, S. Raimondi, Z. Haron, S. Alessi, P. Pricolo, F.A. Mistretta, S. Luzzago, F. Cattani, G. Musi, O. De Cobelli, M. Cremonesi, R. Orecchia, D. La Torre, G. Marvaso, G. Petralia, B.A. Jereczek-Fossa
Precision medicine in breast cancer : From clinical trials to clinical practice
2021 E. Crimini, M. Repetto, P. Aftimos, A. Botticelli, P. Marchetti, G. Curigliano
Research and clinical landscape of bispecific antibodies for the treatment of solid malignancies
2021 G. Antonarelli, F. Giugliano, C. Corti, M. Repetto, P. Tarantino, G. Curigliano
Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions
2021 M. Repetto, E. Crimini, F. Giugliano, S. Morganti, C. Belli, G. Curigliano
Systemic Treatment of Ductal Carcinoma In Situ of the Breast
2021 E. Crimini, C. Corti, M. Repetto, F. Giugliano, G. Antonarelli, P. Tarantino, P. Zagami, S. Morganti, E. Nicolo, J. Uliano, G. Curigliano
Thymic carcinoma with Lynch syndrome or microsatellite instability, a rare entity responsive to immunotherapy
2021 M. Repetto, F. Conforti, S. Pirola, M. Calvello, L. Pala, B. Bonanni, C. Catania, G. Curigliano, T. De Pas